| Nov 8 |
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
|
| Nov 4 |
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
|
| Oct 22 |
BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns
|
| Oct 22 |
BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study
|
| Oct 22 |
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
|
| Oct 15 |
BriaCell gains after update on late-stage trial for lead asset
|
| Oct 15 |
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
|
| Oct 2 |
BriaCell Therapeutics Announces Closing of $5 Million Offering
|
| Oct 2 |
Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
|
| Oct 1 |
BriaCell Therapeutics Announces $5 Million Offering
|
